DAFNA Capital Management LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,046,158
+18.3%
92,887
-1.9%
1.26%
+34.5%
Q2 2023$3,421,511
+25.0%
94,700
+28.7%
0.94%
+14.1%
Q1 2023$2,736,448
-17.9%
73,6000.0%0.82%
-12.7%
Q4 2022$3,334,816
-33.3%
73,600
+2.8%
0.94%
-30.2%
Q3 2022$5,001,000
-6.4%
71,600
-10.1%
1.34%
-7.7%
Q2 2022$5,344,000
+52.2%
79,600
+86.4%
1.46%
+59.2%
Q1 2022$3,511,000
+40.4%
42,700
+95.0%
0.92%
+26.9%
Q2 2020$2,500,000
-22.7%
21,893
-48.0%
0.72%
-46.6%
Q1 2020$3,236,00042,1021.35%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders